# Tumor-Infiltrating Lymphocytes and Response to Neoadjuvant Chemotherapy With or Without Carboplatin in Human Epidermal Growth Factor Receptor 2–Positive and Triple-Negative Primary Breast Cancers

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/tumor-infiltrating-lymphocytes-and-response-to-neoadjuvant-chemotherapy-with-or/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Carsten Denkert,Gϋnter von Minckwitz,Jan C. Brase,Bruno V. Sinn,Stephan Gade,Ralf Kronenwett,Berit M. Pfitzner,Christoph Salat,Sherene Loi,Wolfgang Schmitt,Christian Schem,Karin Fisch,Silvia Darb‐Esfahani,Keyur Mehta,Christos Sotiriou,Stephan Wienert,Peter Klare,Fabrice André,Frederick Klauschen,Jens‐Uwe Blohmer,Kristin Krappmann,Marcus Schmidt,Hans Tesch,Sherko Kümmel,Hans‐Peter Sinn,Christian Jackisch,Manfred Dietel,Toralf Reimer,Michael Untch,Sibylle Loibl |
| Citations | 1,031 |
| DOI | 10.1200/jco.2014.58.1967 |
| Fields | Biochemistry, Genetics and Molecular Biology,Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://zenodo.org/record/3439757 |
| OpenAlex ID | https://openalex.org/W2125885282 |
| PMID | 25534375 |
| Type | article |
| Year | 2014 |

## Paper authors

- [Jens‐Uwe Blohmer](https://scholariq.org/researchers/jens-uwe-blohmer/)

## Paper journal

- [Journal of Clinical Oncology](https://scholariq.org/journals/journal-of-clinical-oncology/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.